{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:37:55Z","timestamp":1787593075995,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.rpth.2023.100129","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T18:55:17Z","timestamp":1679770517000},"page":"100129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Frailty and subsequent adverse outcomes in older patients with atrial fibrillation treated with oral anticoagulants: The Shizuoka study"],"prefix":"10.1016","volume":"7","author":[{"given":"Shiori","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiraku","family":"Kumamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2023.100129_bib1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Original contributions atrial fibrillation as an independent risk factor for stroke: the Framingham study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2023.100129_bib2","doi-asserted-by":"crossref","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et\u00a0al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. 2014;64:e1\u201376. https:\/\/doi.org\/10.1161\/CIR.0000000000000041","DOI":"10.1161\/CIR.0000000000000041"},{"key":"10.1016\/j.rpth.2023.100129_bib3","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation: the Framingham study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2023.100129_bib4","doi-asserted-by":"crossref","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, et\u00a0al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019;140:e125\u201351. https:\/\/doi.org\/10.1161\/CIR.0000000000000665","DOI":"10.1161\/CIR.0000000000000719"},{"key":"10.1016\/j.rpth.2023.100129_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2023.100129_bib6","first-page":"1091","article-title":"Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?","author":"Maes","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.rpth.2023.100129_bib7","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.4022\/jafib.1870","article-title":"What is the impact of frailty on prescription of anticoagulation in elderly patients with atrial fibrillation? A systematic review and meta-analysis","volume":"10","author":"Oqab","year":"2018","journal-title":"J\u00a0Atr Fibrillation"},{"key":"10.1016\/j.rpth.2023.100129_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ahj.2014.07.002","article-title":"Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"168","author":"O\u2019Brien","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.rpth.2023.100129_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2023.100129_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ageing\/afl129","article-title":"A\u00a0randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)","volume":"36","author":"Rash","year":"2007","journal-title":"Age Ageing"},{"key":"10.1016\/j.rpth.2023.100129_bib11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2023.100129_bib12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ageing\/afaa265","article-title":"Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study","volume":"50","author":"Wilkinson","year":"2021","journal-title":"Age Ageing"},{"key":"10.1016\/j.rpth.2023.100129_bib13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2459\/JCM.0000000000000986","article-title":"Direct oral anticoagulants for patients aged over 80 years in nonvalvular atrial fibrillation: the impact of frailty","volume":"21","author":"De Simone","year":"2020","journal-title":"J\u00a0Cardiovasc Med"},{"key":"10.1016\/j.rpth.2023.100129_bib14","doi-asserted-by":"crossref","first-page":"e011212","DOI":"10.1136\/heartasia-2019-011212","article-title":"The influence of frailty under direct oral anticoagulant use in patients with atrial fibrillation","volume":"11","author":"Yamamoto","year":"2019","journal-title":"Heart Asia"},{"key":"10.1016\/j.rpth.2023.100129_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-01870-w","article-title":"Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial","volume":"18","author":"Wilkinson","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.rpth.2023.100129_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001232","article-title":"Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data","volume":"7","author":"Kohsaka","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.rpth.2023.100129_bib17","first-page":"391","article-title":"Data resource profile of Shizuoka Kokuho Database (SKDB) using integrated health- and care-insurance claims and health checkups: the Shizuoka study","volume":"32","author":"Nakatani","year":"2021","journal-title":"J\u00a0Epidemiol"},{"key":"10.1016\/j.rpth.2023.100129_bib18","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1253\/circj.CJ-12-0454","article-title":"Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation\u2014the J-ROCKET AF study","volume":"76","author":"Hori","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.rpth.2023.100129_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ageing\/afw039","article-title":"Development and validation of an electronic frailty index using routine primary care electronic health record data","volume":"45","author":"Clegg","year":"2016","journal-title":"Age Ageing"},{"key":"10.1016\/j.rpth.2023.100129_bib20","doi-asserted-by":"crossref","first-page":"afac009","DOI":"10.1093\/ageing\/afac009","article-title":"Assessment of coding-based frailty algorithms for long-term outcome prediction among older people in community settings: a cohort study from the Shizuoka Kokuho Database","volume":"51","author":"Nishimura","year":"2022","journal-title":"Age Ageing"},{"key":"10.1016\/j.rpth.2023.100129_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11319540-000000000-00000","article-title":"Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study","volume":"27","author":"Tulner","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.rpth.2023.100129_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1253\/circj.CJ-20-0373","article-title":"Impact of frailty on bleeding events related to anticoagulation therapy in patients with atrial fibrillation","volume":"85","author":"Ohta","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.rpth.2023.100129_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101527","article-title":"Impact of frailty on all-cause mortality and major bleeding in patients with atrial fibrillation: a meta-analysis","volume":"73","author":"He","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.rpth.2023.100129_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/STROKEAHA.114.007199","article-title":"Stroke and major bleeding risk in elderly patients aged \u2265 75 years with atrial fibrillation: the Loire Valley atrial fibrillation project","volume":"46","author":"Lip","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2023.100129_bib25","article-title":"Thromboembolic risk, bleeding outcomes and effect of different antithrombotic strategies in very elderly patients with atrial fibrillation: a sub-analysis from the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation)","volume":"6","author":"Patti","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.rpth.2023.100129_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.amjmed.2012.01.033","article-title":"Risk of falls and major bleeds in patients on oral anticoagulation therapy","volume":"125","author":"Donz\u00e9","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2023.100129_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101761","article-title":"Impact of frailty models on the prescription of oral anticoagulants and on the incidence of stroke, bleeding, and mortality in older patients with atrial fibrillation: a systematic review","volume":"82","author":"Presta","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.rpth.2023.100129_bib28","doi-asserted-by":"crossref","first-page":"E2228500","DOI":"10.1001\/jamanetworkopen.2022.28500","article-title":"Outcomes and safety of very-low-dose edoxaban in frail patients with atrial fibrillation in the ELDERCARE-AF randomized clinical trial","volume":"5","author":"Akashi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.rpth.2023.100129_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ageing\/afy180","article-title":"Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis","volume":"48","author":"Wilkinson","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.rpth.2023.100129_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2019.01.005","article-title":"Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation","volume":"211","author":"Madhavan","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.rpth.2023.100129_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ehjqcco\/qcaa002","article-title":"Frailty to predict unplanned hospitalization, stroke, bleeding, and death in atrial fibrillation","volume":"7","author":"Gugganig","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.rpth.2023.100129_bib32","first-page":"77","article-title":"The introduction of direct oral anticoagulants has not resolved treatment gaps for frail patients with nonvalvular atrial fibrillation","volume":"38","author":"Orlandi","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.rpth.2023.100129_bib33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2023.100129_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37288","article-title":"Clinician trends in prescribing direct oral anticoagulants for US Medicare beneficiaries","volume":"4","author":"Wheelock","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.rpth.2023.100129_bib35","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1253\/circj.CJ-18-0989","article-title":"Trends in prevalence of non-valvular atrial fibrillation and anticoagulation therapy in a Japanese region analysis using the national health insurance database","volume":"84","author":"Narita","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.rpth.2023.100129_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-020-5058-1","article-title":"Trends in anticoagulant prescribing: a review of local policies in English primary care","volume":"20","author":"Ho","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.rpth.2023.100129_bib37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s11239-021-02416-4","article-title":"Prescribing trends of oral anticoagulants in England over the last decade: a focus on new and old drugs and adverse events reporting","volume":"52","author":"Afzal","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923001000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923001000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:25:24Z","timestamp":1762863924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037923001000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2475037923001000"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100129","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frailty and subsequent adverse outcomes in older patients with atrial fibrillation treated with oral anticoagulants: The Shizuoka study","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"100129"}}